ACAAI 2024: Clinical Impact of New Food Allergy Recommendations for Prevention and Treatment

Ruchi Gupta, MD, MPH

November 15, 2024

Ruchi Gupta, MD, offers key takeaways with practical implications from the ACAAI 2024 meeting, focusing on food allergy prevention and management. For children with severe eczema, new guidelines recommend introducing peanut products early, even without testing, to reduce the risk of developing food allergies. Pediatricians are advised to engage in shared decision-making with parents, offering guidance on safe introduction or referring for allergy testing when necessary.

Dr Gupta also discusses emerging treatments for food allergies, including oral immunotherapy (OIT) and biologic omalizumab. OIT gradually increases a patient’s tolerance to allergens, while omalizumab helps boost tolerance and reduce severe reactions. Dr Gupta concludes by encouraging primary care providers to stay informed about these options and discuss them with patients who may benefit.

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: ACAAI 2024: Clinical Impact of New Food Allergy Recommendations for Prevention and Treatment - Medscape - Nov 15, 2024.

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.